Surely Big Pharma corporations are spending their cash on research ‘for the cure’ and finding ways to implement life-saving ingredients into their next formula, right? As it turns out, 9 out of 10 Big Pharma companies actually spent more on their sales and marketing than their research and development.
In the infographic below, checkout the 2013 spending habits of the top 10 Big Pharma corporations:
What happens when mega pharmaceutical companies get their new grip around one of the oldest asthma medications that many rely on for daily use? Based on historical data, it appears that one of the first action items is to exponentially increase the price of the same medication without any actual advancements of any kind. It’s a process that is involved with ‘repatenting.’
Marijuana and its use has been studied over the course of the last few decades more so than even many leading FDA-approved pharmaceutical drugs, with researchers categorizing the effects of marijuana to a much greater degree than many of the pharmaceutical drugs you or your family may currently be taking.
There is good news and bad news when it comes to conflicts of interest (COI) between the drug industry and clinical medicine. The good news is the “Sunshine Act,” part of the Affordable Care Act, has been implemented and many drug company web sites now list the payouts–including to “grassroots” groups that are actually Pharma fronts like the National Alliance on Mental Illness (NAMI).
Oh say can you see by the star spangled machine, with modern weapons in hand it conquers foreign lands. If uninhabited, these lands would be up for the taking. And while the U.S. Declaration of Independence says “all men are created equal” with “inalienable rights”, the U.S. has a history of internal conflicts arising from violating those principles domestically and through foreign policy. Since the event of 9/11 the U.S.
Did you or your children use the blockbuster asthma drug Singulair? World sales of Merck’s drug were about $5 billion a year until 2012 when its patent expired and it was the U.S.’s seventh best-selling drug. But last month, data from an FDA committee were presented that acknowledge “safety concerns” about “neuropsychiatric adverse events, including suicide and suicide attempts” with the drug.
One out of four people has a “mental illness.” You hear the statistic all the time. People who were once “nervous” or “high strung” now have “general anxiety disorder.” People who have the “blues” from real life issues like job, relationship and family problems now have “major depressive disorder.” People who are “up and down,” again from real life issues, are now “bipolar.” Adults who can’t focus on the work at hand, either because they didn’t get enough sleep or because the work at hand is boring – hello? — have adult ADHD.
Are you depressed? Have you lost interest in things you used to enjoy? Are you eating or sleeping too much? Big Pharma hopes so! The push to convince people who are dealing with job, family, relationship and money problems that they actually have “depression” has resulted in almost one in four American women in their 40s and 50s taking antidepressants. Ka-ching.
No one should have to choose between their hairline and their health. But increasingly, men who use Finasteride, commonly known as Propecia, to treat their male pattern baldness are making that choice, often unwittingly. In the 17 years since Propecia was approved to treat hair loss from male pattern baldness, so many disturbing urogenital and other side effects have emerged, the term Post Finasteride Syndrome (PFS) has been coined and hundreds of lawsuits have been brought.
For those who believe in marijuana and cannabis freedom, the future has never been brighter. Right now there is an awakening to the benefits of cannabis for medicinal purposes, specifically something called CBD oil. But is the new CBD craze being manipulated by media and politicians?
